vs

Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and CARRIAGE SERVICES INC (CSV). Click either name above to swap in a different company.

CARRIAGE SERVICES INC is the larger business by last-quarter revenue ($105.5M vs $83.5M, roughly 1.3× BillionToOne, Inc.). CARRIAGE SERVICES INC runs the higher net margin — 11.6% vs 6.8%, a 4.8% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 8.0%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $6.2M).

BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.

Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.

BLLN vs CSV — Head-to-Head

Bigger by revenue
CSV
CSV
1.3× larger
CSV
$105.5M
$83.5M
BLLN
Growing faster (revenue YoY)
BLLN
BLLN
+109.4% gap
BLLN
117.4%
8.0%
CSV
Higher net margin
CSV
CSV
4.8% more per $
CSV
11.6%
6.8%
BLLN
More free cash flow
BLLN
BLLN
$247.0K more FCF
BLLN
$6.5M
$6.2M
CSV

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BLLN
BLLN
CSV
CSV
Revenue
$83.5M
$105.5M
Net Profit
$5.7M
$12.3M
Gross Margin
69.9%
34.8%
Operating Margin
11.5%
23.3%
Net Margin
6.8%
11.6%
Revenue YoY
117.4%
8.0%
Net Profit YoY
138.3%
24.5%
EPS (diluted)
$0.10
$0.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLLN
BLLN
CSV
CSV
Q4 25
$105.5M
Q3 25
$83.5M
$102.7M
Q2 25
$102.1M
Q1 25
$107.1M
Q4 24
$97.7M
Q3 24
$38.4M
$100.7M
Q2 24
$102.3M
Q1 24
$103.5M
Net Profit
BLLN
BLLN
CSV
CSV
Q4 25
$12.3M
Q3 25
$5.7M
$6.6M
Q2 25
$11.7M
Q1 25
$20.9M
Q4 24
$9.9M
Q3 24
$-14.9M
$9.9M
Q2 24
$6.3M
Q1 24
$7.0M
Gross Margin
BLLN
BLLN
CSV
CSV
Q4 25
34.8%
Q3 25
69.9%
35.3%
Q2 25
35.2%
Q1 25
35.3%
Q4 24
34.4%
Q3 24
52.6%
35.2%
Q2 24
36.2%
Q1 24
36.0%
Operating Margin
BLLN
BLLN
CSV
CSV
Q4 25
23.3%
Q3 25
11.5%
17.0%
Q2 25
23.5%
Q1 25
29.5%
Q4 24
21.6%
Q3 24
-32.9%
22.7%
Q2 24
18.0%
Q1 24
18.8%
Net Margin
BLLN
BLLN
CSV
CSV
Q4 25
11.6%
Q3 25
6.8%
6.4%
Q2 25
11.5%
Q1 25
19.5%
Q4 24
10.1%
Q3 24
-38.8%
9.8%
Q2 24
6.1%
Q1 24
6.7%
EPS (diluted)
BLLN
BLLN
CSV
CSV
Q4 25
$0.76
Q3 25
$0.10
$0.41
Q2 25
$0.74
Q1 25
$1.34
Q4 24
$0.62
Q3 24
$-1.47
$0.63
Q2 24
$0.40
Q1 24
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLLN
BLLN
CSV
CSV
Cash + ST InvestmentsLiquidity on hand
$195.2M
$1.7M
Total DebtLower is stronger
$55.0M
Stockholders' EquityBook value
$-239.5M
$254.8M
Total Assets
$327.5M
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLLN
BLLN
CSV
CSV
Q4 25
$1.7M
Q3 25
$195.2M
$1.2M
Q2 25
$1.4M
Q1 25
$4.6M
Q4 24
$1.2M
Q3 24
$1.3M
Q2 24
$1.5M
Q1 24
$1.7M
Total Debt
BLLN
BLLN
CSV
CSV
Q4 25
Q3 25
$55.0M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BLLN
BLLN
CSV
CSV
Q4 25
$254.8M
Q3 25
$-239.5M
$242.1M
Q2 25
$235.4M
Q1 25
$223.1M
Q4 24
$208.6M
Q3 24
$-242.9M
$198.1M
Q2 24
$187.9M
Q1 24
$179.6M
Total Assets
BLLN
BLLN
CSV
CSV
Q4 25
$1.3B
Q3 25
$327.5M
$1.3B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLLN
BLLN
CSV
CSV
Operating Cash FlowLast quarter
$13.8M
$14.1M
Free Cash FlowOCF − Capex
$6.5M
$6.2M
FCF MarginFCF / Revenue
7.7%
5.9%
Capex IntensityCapex / Revenue
8.8%
7.5%
Cash ConversionOCF / Net Profit
2.42×
1.15×
TTM Free Cash FlowTrailing 4 quarters
$40.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLLN
BLLN
CSV
CSV
Q4 25
$14.1M
Q3 25
$13.8M
$24.7M
Q2 25
$8.1M
Q1 25
$13.8M
Q4 24
$9.3M
Q3 24
$20.9M
Q2 24
$2.2M
Q1 24
$19.7M
Free Cash Flow
BLLN
BLLN
CSV
CSV
Q4 25
$6.2M
Q3 25
$6.5M
$18.0M
Q2 25
$5.2M
Q1 25
$10.6M
Q4 24
$4.9M
Q3 24
$16.2M
Q2 24
$-1.4M
Q1 24
$16.2M
FCF Margin
BLLN
BLLN
CSV
CSV
Q4 25
5.9%
Q3 25
7.7%
17.5%
Q2 25
5.1%
Q1 25
9.9%
Q4 24
5.0%
Q3 24
16.1%
Q2 24
-1.4%
Q1 24
15.6%
Capex Intensity
BLLN
BLLN
CSV
CSV
Q4 25
7.5%
Q3 25
8.8%
6.5%
Q2 25
2.8%
Q1 25
3.0%
Q4 24
4.5%
Q3 24
4.6%
Q2 24
3.5%
Q1 24
3.4%
Cash Conversion
BLLN
BLLN
CSV
CSV
Q4 25
1.15×
Q3 25
2.42×
3.76×
Q2 25
0.69×
Q1 25
0.66×
Q4 24
0.94×
Q3 24
2.11×
Q2 24
0.34×
Q1 24
2.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BLLN
BLLN

Prenatal$74.1M89%
Oncology$8.7M10%

CSV
CSV

Propertyand Merchandise$47.8M45%
Cemetery Interment Rights$24.8M23%
Merchandise$18.9M18%
Other Revenue$10.2M10%
Other$3.9M4%

Related Comparisons